{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:37Z","timestamp":1789473937637,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":240,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2026.102497","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:50:22Z","timestamp":1788245422000},"page":"102497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lung cancer in patients with scleroderma-associated interstitial lung disease: Case series and implications for screening"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-2809","authenticated-orcid":false,"given":"Omar","family":"El Fadel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos-Dionysios","family":"Alysandratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmcr.2026.102497_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatol Oxf Engl"},{"issue":"10","key":"10.1016\/j.rmcr.2026.102497_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102633","article-title":"Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis","volume":"19","author":"Peng","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.rmcr.2026.102497_bib3","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/acr.24076","article-title":"Incidence, risk factors, and outcomes of cancer in systemic sclerosis","volume":"72","author":"Morrisroe","year":"2020","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.rmcr.2026.102497_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/oncolo\/oyac226","article-title":"Management of lung cancer in the patient with interstitial lung disease","volume":"28","author":"Frank","year":"2023","journal-title":"Oncologist"},{"issue":"16","key":"10.1016\/j.rmcr.2026.102497_bib5","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3390\/cancers16162837","article-title":"Lung cancer and interstitial lung diseases","volume":"16","author":"Drakopanagiotakis","year":"2024","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.rmcr.2026.102497_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41584-022-00841-0","article-title":"Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases","volume":"18","author":"Tison","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102497_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PPO.0000000000000484","article-title":"Immunotherapy use in patients with lung cancer and comorbidities","volume":"26","author":"von Itzstein","year":"2020","journal-title":"Cancer J Sudbury Mass"},{"issue":"1","key":"10.1016\/j.rmcr.2026.102497_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1513\/AnnalsATS.202301-054OC","article-title":"Mycophenolate in patients with systemic sclerosis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"21","author":"Herman","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"3","key":"10.1016\/j.rmcr.2026.102497_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/ijms20030593","article-title":"Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets","volume":"20","author":"Ballester","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.rmcr.2026.102497_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212179","article-title":"Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development","volume":"22","author":"Samarelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmcr.2026.102497_bib11","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","article-title":"Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors","volume":"9","author":"Maria","year":"2019","journal-title":"Front. Immunol."},{"issue":"5 Suppl","key":"10.1016\/j.rmcr.2026.102497_bib12","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.12-2345","article-title":"Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Alberg","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmcr.2026.102497_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.athoracsur.2019.11.052","article-title":"Age, race, and income are associated with lower screening rates at a safety net hospital","volume":"109","author":"Steiling","year":"2020","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.rmcr.2026.102497_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MCP.0000000000000975","article-title":"Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease","volume":"29","author":"Azhar","year":"2023","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"12","key":"10.1016\/j.rmcr.2026.102497_bib15","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clon.2022.01.043","article-title":"Is thoracic radiotherapy an absolute contraindication for treatment of lung cancer patients with interstitial lung disease? A systematic review","volume":"34","author":"Saha","year":"2022","journal-title":"Clin. Oncol. R Coll. Radiol. G B"},{"issue":"7","key":"10.1016\/j.rmcr.2026.102497_bib16","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.40114","article-title":"Mycophenolate mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of scleroderma lung studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"issue":"2\u20133","key":"10.1016\/j.rmcr.2026.102497_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"6","key":"10.1016\/j.rmcr.2026.102497_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.rmcr.2026.102497_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1164\/rccm.202103-0714OC","article-title":"Long-term safety and efficacy of Tocilizumab in early systemic sclerosis-interstitial lung disease: open-label extension of a phase 3 randomized controlled trial","volume":"205","author":"Khanna","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmcr.2026.102497_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial","volume":"15","author":"Reck","year":"2014","journal-title":"Lancet Oncol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007126001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:34:54Z","timestamp":1789472094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007126001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["S2213007126001346"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102497","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung cancer in patients with scleroderma-associated interstitial lung disease: Case series and implications for screening","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2026.102497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102497"}}